高盛David Roman：AI将助力糖尿病管理
2026-06-16 22:13:34
高盛美国医疗科技与医疗IT研究分析师David Roman称，AI将在帮助患者管理糖尿病方面发挥“重要”作用，雅培和Dexcom正用新技术计算碳水并提供合适剂量胰岛素。据 Bloomberg 报道，他在高盛年度医疗科技大会后对行业创新“非常看多”。
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
STOCKS | Asian Stocks Poised to End Three-Day Rally as Wall Street Slides Ahead of Fed DecisionNext article：
股票市场 | 亚股料终结三连涨 跟随美股回落
